NIH-funded research R21 grant

Improving newborn screening methods for genetic disorders

Official title: Optimal newborn screening algorithms - efficacy and equity

Funded at University of Alabama in Tuscaloosa · NIH-10790222 · Data updated 2026-11-12

This study is working to improve the way newborns are tested for genetic disorders like cystic fibrosis, especially for babies in underserved areas, so that all parents can trust their little ones are getting the right tests and care right from the start.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Alabama in Tuscaloosa
NIH-funded
Lab location1 site (Tuscaloosa, United States)
Project startSeptember 10, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$223,500
NIH project number1R21HD113958-01
Project IDNIH-10790222 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include newborns, particularly those from African American populations, who are undergoing routine screening for genetic disorders.

Less likely to help

Patients who are not newborns or those who do not belong to populations targeted by the screening algorithms may not benefit from this research.

What this research studies

This research focuses on enhancing newborn screening (NBS) algorithms to ensure that all newborns, particularly those in underserved populations, receive accurate and timely testing for genetic disorders like cystic fibrosis. The project aims to create a comprehensive framework that optimizes the combination of tests used in NBS, addressing the variability in testing practices across different states. By analyzing existing screening methods and their outcomes, the research seeks to reduce false positives and negatives, ultimately improving the effectiveness of early diagnosis and treatment for newborns. Parents of newborns will benefit from more reliable screening processes that can lead to better health outcomes for their children.

Why it matters

Potential benefit: If successful, this research could lead to more accurate and equitable newborn screening, ensuring early detection of genetic disorders and improved health outcomes for affected infants.

How similar studies have gone: Previous research has shown that optimizing screening algorithms can significantly improve diagnostic accuracy and reduce healthcare costs, indicating a promising avenue for this study.

Where this research is happening

  • University of Alabama in Tuscaloosa
    Tuscaloosa, United States
    Active

Researchers

  • Principal investigator: Bish, Douglas — University of Alabama in Tuscaloosa
  • Study coordinator: Bish, Douglas

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.